Hematopoietic Agents
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ELTROMBOPAG OLAMINE: products 1 to 4 of 4.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Eltrombopag 25mg TabDIN 02506742 | Off-Formulary Interchangeable, not an ODB benefit | $55.2500per source unit | Requirements & sourcesBuild cost plan |
| Apo-Eltrombopag 50mg TabDIN 02506769 | Off-Formulary Interchangeable, not an ODB benefit | $110.5000per source unit | Requirements & sourcesBuild cost plan |
| Revolade 25mg TabDIN 02361825 | Off-Formulary Interchangeable, not an ODB benefit | $55.2500per source unit | Requirements & sourcesBuild cost plan |
| Revolade 50mg TabDIN 02361833 | Off-Formulary Interchangeable, not an ODB benefit | $110.5000per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
20:16 Hematopoietic Agents.